You are here

Article Text

Article menu
Download PDFPDF
PostScript
Correspondence
The lymphocyte-monocyte ratio in clinical practice
  1. Sevket Balta1,
  2. Zafer Demırer2,
  3. Mustafa Aparci3,
  4. Ali Osman Yildirim1,
  5. Cengiz Ozturk1
  1. 1 Department of Cardiology, Gulhane Medical Faculty, Ankara, Turkey
  2. 2 Department of Urology, Eskişehir Military Hospital, Eskişehir, Turkey
  3. 3 Department of Cardiology, Kasimpasa Military Hospital, Istanbul, Turkey
  1. Correspondence to Dr Sevket Balta, Department of Cardiology, Gulhane School of Medicine, Tevfik Saglam St., Etlik-Ankara 06018, Turkey; drsevketb{at}gmail.com, sevketb{at}gata.edu.tr

https://doi.org/10.1136/jclinpath-2015-203233

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We read the article ‘Pretreatment lymphocyte-monocyte ratio (LMR) as a potential prognostic factor in a cohort of patients with upper tract urothelial carcinoma’ by Hutterer et al.1 They aimed to investigate the potential prognostic impact of the LMR in a large European cohort of patients with localised upper urinary tract urothelial carcinoma. They concluded that LMR might be considered an additional prognostic factor in upper urinary tract urothelial carcinoma in the future.

    A complete blood count is an easy examination technique that gives us information about the patients’ formed …

    View Full Text

    Footnotes

    • Competing interests None declared.

    • Patient consent Obtained.

    • Provenance and peer review Not commissioned; internally peer reviewed.